1 1252 132 FEASIBILITY, ACCEPTABILITY AND EVALUATION OF MEDITATION TO AUGMENT YOGA PRACTICE AMONG PERSONS DIAGNOSED WITH SCHIZOPHRENIA. OBJECTIVE: TO DESIGN A MEDITATION PROTOCOL AND TEST ITS FEASIBILITY, ACCEPTABILITY AND EFFICACY IN CONJUNCTION WITH YT FOR PERSONS WITH SCHIZOPHRENIA (SZ). METHODS: THE MEDITATION PROTOCOL CONSISTED OF ANAPANA (OBSERVING NORMAL RESPIRATION) AND YOGA NIDRA (SUPINE, RESTFUL AWARENESS). IN A SINGLE BLIND RANDOMIZED CONTROLLED TRIAL, MEDICATED AND CLINICALLY STABLE OUTPATIENTS DIAGNOSED WITH SZ WERE RANDOMIZED TO RECEIVE TREATMENT AS USUAL (TAU), TAU AUGMENTED WITH YOGA TRAINING (YT), OR TAU AUGMENTED WITH MEDITATION AND YOGA TRAINING (MYT) FOR THREE WEEKS (N=145). ACCEPTABILITY, CLINICAL, SOCIAL AND COGNITIVE FUNCTIONS WERE ASSESSED AFTER 3 WEEKS AND 3 MONTHS POST RANDOMIZATION USING WITHIN GROUP AND BETWEEN GROUPS ANALYSES WITH REPEATED MEASURES MULTIVARIATE TESTS. RESULTS: NO GROUP-WISE DIFFERENCES IN COMPLIANCE, STUDY DISCONTINUATION, MAJOR/SERIOUS SIDE EFFECTS OR ADVERSE EVENTS WERE NOTED. FOR SIX ASSESSED CLINICAL VARIABLES, THE DIRECTION OF CHANGES WERE IN THE DESIRED DIRECTION AND THE EFFECT SIZES WERE GREATER IN THE MYT GROUP COMPARED WITH THE TAU GROUP AT BOTH TIME POINTS. CHANGES IN SOCIAL FUNCTION VARIABLES WERE GREATER AT 3 MONTHS THAN AT 3 WEEKS. NOMINALLY SIGNIFICANT IMPROVEMENT IN INDIVIDUAL COGNITIVE DOMAINS WERE NOTED IN ALL GROUPS AT BOTH TIME POINTS. ALL EFFECT SIZES WERE IN THE SMALL TO MEDIUM RANGE. CONCLUSION: MYT IS FEASIBLE, ACCEPTABLE AND SHOWS MODEST BENEFITS FOR PERSONS WITH SZ. MYT CAN ALSO IMPROVE QUALITY OF LIFE AND CLINICAL SYMPTOMS. LARGER STUDIES OF LONGER DURATION ARE WARRANTED. 2022 2 288 53 ADJUNCTIVE COGNITIVE REMEDIATION FOR SCHIZOPHRENIA USING YOGA: AN OPEN, NON-RANDOMIZED TRIAL. BACKGROUND: YOGA THERAPY (YT) IMPROVES COGNITIVE FUNCTION IN HEALTHY INDIVIDUALS, BUT ITS IMPACT ON COGNITIVE FUNCTION AMONG PERSONS WITH SCHIZOPHRENIA (SZ) HAS NOT BEEN INVESTIGATED. AIMS: EVALUATE ADJUNCTIVE YT FOR COGNITIVE DOMAINS IMPAIRED IN SZ. METHODS: PATIENTS WITH SZ RECEIVED YT OR TREATMENT AS USUAL (TAU; N = 65, N = 23, RESPECTIVELY). ACCURACY AND SPEED FOR SEVEN COGNITIVE DOMAINS WERE ASSESSED USING A COMPUTERIZED NEUROCOGNITIVE BATTERY (CNB), THUS MINIMIZING OBSERVER BIAS. SEPARATELY, YT WAS EVALUATED AMONG PATIENTS WITH BIPOLAR I DISORDER (N = 40), MAJOR DEPRESSIVE DISORDER (N = 37), AND CARDIOLOGY OUTPATIENTS (N = 68). ALL PATIENTS ALSO RECEIVED ROUTINE PHARMACOTHERAPY. PATIENTS WERE NOT RANDOMIZED TO YT OR TAU. RESULTS: COMPARED WITH THE SZ/TAU GROUP, THE SZ/YT GROUP SHOWED SIGNIFICANTLY GREATER IMPROVEMENT WITH REGARD TO MEASURES OF ATTENTION FOLLOWING CORRECTIONS FOR MULTIPLE COMPARISONS; THE CHANGES WERE MORE PROMINENT AMONG THE MEN. IN THE OTHER DIAGNOSTIC GROUPS, DIFFERING PATTERNS OF IMPROVEMENTS WERE NOTED WITH SMALL TO MEDIUM EFFECT SIZES. CONCLUSIONS: OUR INITIAL ANALYSES SUGGEST NOMINALLY SIGNIFICANT IMPROVEMENT IN COGNITIVE FUNCTION IN SCHIZOPHRENIA WITH ADJUNCTIVE THERAPIES SUCH AS YT. THE MAGNITUDE OF THE CHANGE VARIES BY COGNITIVE DOMAIN AND MAY ALSO VARY BY DIAGNOSTIC GROUP. 2012 3 161 49 A RANDOMISED CONTROLLED TRIAL OF ADJUNCTIVE YOGA AND ADJUNCTIVE PHYSICAL EXERCISE TRAINING FOR COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA. BACKGROUND: YOGA AND PHYSICAL EXERCISE HAVE BEEN USED AS ADJUNCTIVE INTERVENTION FOR COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA (SZ), BUT CONTROLLED COMPARISONS ARE LACKING. AIMS A SINGLE-BLIND RANDOMISED CONTROLLED TRIAL WAS DESIGNED TO EVALUATE WHETHER YOGA TRAINING OR PHYSICAL EXERCISE TRAINING ENHANCE COGNITIVE FUNCTIONS IN SZ, BASED ON A PRIOR PILOT STUDY. METHODS: CONSENTING, CLINICALLY STABLE, ADULT OUTPATIENTS WITH SZ (N=286) COMPLETED BASELINE ASSESSMENTS AND WERE RANDOMISED TO TREATMENT AS USUAL (TAU), SUPERVISED YOGA TRAINING WITH TAU (YT) OR SUPERVISED PHYSICAL EXERCISE TRAINING WITH TAU (PE). BASED ON THE PILOT STUDY, THE PRIMARY OUTCOME MEASURE WAS SPEED INDEX FOR THE COGNITIVE DOMAIN OF 'ATTENTION' IN THE PENN COMPUTERISED NEUROCOGNITIVE BATTERY. USING MIXED MODELS AND CONTRASTS, COGNITIVE FUNCTIONS AT BASELINE, 21 DAYS (END OF TRAINING), 3 AND 6 MONTHS POST-TRAINING WERE EVALUATED WITH INTENTION-TO-TREAT PARADIGM. RESULTS: SPEED INDEX OF ATTENTION DOMAIN IN THE YT GROUP SHOWED GREATER IMPROVEMENT THAN PE AT 6 MONTHS FOLLOW-UP (P<0.036, EFFECT SIZE 0.51). IN THE PE GROUP, 'ACCURACY INDEX OF ATTENTION DOMAIN SHOWED GREATER IMPROVEMENT THAN TAU ALONE AT 6-MONTH FOLLOW-UP (P<0.025, EFFECT SIZE 0.61). FOR SEVERAL OTHER COGNITIVE DOMAINS, SIGNIFICANT IMPROVEMENTS WERE OBSERVED WITH YT OR PE COMPARED WITH TAU ALONE (P<0.05, EFFECT SIZES 0.30-1.97). CONCLUSIONS: BOTH YT AND PE IMPROVED ATTENTION AND ADDITIONAL COGNITIVE DOMAINS WELL PAST THE TRAINING PERIOD, SUPPORTING OUR PRIOR REPORTED BENEFICIAL EFFECT OF YT ON SPEED INDEX OF ATTENTION DOMAIN. AS ADJUNCTS, YT OR PE CAN BENEFIT INDIVIDUALS WITH SZ. 2017 4 289 48 ADJUNCTIVE YOGA TRAINING FOR PERSONS WITH SCHIZOPHRENIA: WHO BENEFITS? OBJECTIVE: THE AIM OF THIS STUDY WAS TO IDENTIFY FACTORS ASSOCIATED WITH ACCEPTABILITY AND EFFICACY OF YOGA TRAINING (YT) FOR IMPROVING COGNITIVE DYSFUNCTION IN INDIVIDUALS WITH SCHIZOPHRENIA (SZ). METHODS: WE ANALYSED DATA FROM TWO PUBLISHED CLINICAL TRIALS OF YT FOR COGNITIVE DYSFUNCTION AMONG INDIANS WITH SZ: (1) A 21-DAY RANDOMISED CONTROLLED TRIAL (RCT, N = 286), 3 AND 6 MONTHS FOLLOW-UP AND (2) A 21-DAY OPEN TRIAL (N = 62). MULTIVARIATE ANALYSES WERE CONDUCTED TO EXAMINE THE ASSOCIATION OF BASELINE CHARACTERISTICS (AGE, SEX, SOCIO-ECONOMIC STATUS, EDUCATIONAL STATUS, DURATION, AND SEVERITY OF ILLNESS) WITH IMPROVEMENT IN COGNITION (I.E. ATTENTION AND FACE MEMORY) FOLLOWING YT. FACTORS ASSOCIATED WITH ACCEPTABILITY WERE IDENTIFIED BY COMPARING BASELINE DEMOGRAPHIC VARIABLES BETWEEN SCREENED AND ENROLLED PARTICIPANTS AS WELL AS COMPLETERS VERSUS NON-COMPLETERS. RESULTS: ENROLLED PARTICIPANTS WERE YOUNGER THAN SCREENED PERSONS WHO DECLINED PARTICIPATION (T = 2.952, P = 0.003). NO OTHER CHARACTERISTICS WERE ASSOCIATED WITH STUDY ENROLLMENT OR COMPLETION. REGARDING EFFICACY, SCHOOLING DURATION WAS NOMINALLY ASSOCIATED WITH GREATER AND SUSTAINED COGNITIVE IMPROVEMENT ON A MEASURE OF FACIAL MEMORY. NO OTHER BASELINE CHARACTERISTICS WERE ASSOCIATED WITH EFFICACY OF YT IN THE OPEN TRIAL, THE RCT, OR THE COMBINED SAMPLES (N = 148). CONCLUSIONS: YT IS ACCEPTABLE EVEN AMONG YOUNGER INDIVIDUALS WITH SZ. IT ALSO ENHANCES SPECIFIC COGNITIVE FUNCTIONS, REGARDLESS OF INDIVIDUAL DIFFERENCES IN SELECTED PSYCHOSOCIAL CHARACTERISTICS. THUS, YOGA COULD BE INCORPORATED AS ADJUNCTIVE THERAPY FOR PATIENTS WITH SZ. IMPORTANTLY, OUR RESULTS SUGGEST COGNITIVE DYSFUNCTION IS REMEDIABLE IN PERSONS WITH SZ ACROSS THE AGE SPECTRUM. 2021 5 2293 50 THERAPEUTIC EFFICACY OF ADD-ON YOGASANA INTERVENTION IN STABILIZED OUTPATIENT SCHIZOPHRENIA: RANDOMIZED CONTROLLED COMPARISON WITH EXERCISE AND WAITLIST. BACKGROUND: SCHIZOPHRENIA IS A HIGHLY DISABLING ILLNESS. PREVIOUS STUDIES HAVE SHOWN YOGA TO BE A FEASIBLE ADD-ON THERAPY IN SCHIZOPHRENIA. AIMS: THE CURRENT STUDY AIMED TO TEST THE EFFICACY OF YOGA AS AN ADD-ON TREATMENT IN OUTPATIENTS WITH SCHIZOPHRENIA. SETTINGS AND DESIGN: THE STUDY DONE AT A TERTIARY PSYCHIATRY CENTER USED A SINGLE BLIND RANDOMIZED CONTROLLED DESIGN WITH ACTIVE CONTROL AND WAITLIST GROUPS. MATERIALS AND METHODS: CONSENTING PATIENTS WITH SCHIZOPHRENIA WERE RANDOMIZED INTO YOGA, EXERCISE, OR WAITLIST GROUP. THEY CONTINUED TO RECEIVE PHARMACOLOGICAL THERAPY THAT WAS UNCHANGED DURING THE STUDY. PATIENTS IN THE YOGA OR EXERCISE GROUP WERE OFFERED SUPERVISED DAILY PROCEDURES FOR ONE MONTH. ALL PATIENTS WERE ASSESSED BY A BLIND RATER AT THE START OF THE INTERVENTION AND AT THE END OF 4 MONTHS. RESULTS: KENDALL TAU, A NONPARAMETRIC STATISTICAL TEST, SHOWED THAT SIGNIFICANTLY MORE PATIENTS IN THE YOGA GROUP IMPROVED IN POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) NEGATIVE AND TOTAL PANSS SCORES AS WELL AS SOCIAL FUNCTIONING SCORES COMPARED WITH THE EXERCISE AND WAITLIST GROUP. ODDS RATIO ANALYSIS SHOWED THAT THE LIKELIHOOD OF IMPROVEMENT IN YOGA GROUP IN TERMS OF NEGATIVE SYMPTOMS WAS ABOUT FIVE TIMES GREATER THAN EITHER THE EXERCISE OR WAITLIST GROUPS. CONCLUSION: IN SCHIZOPHRENIA PATIENTS WITH SEVERAL YEARS OF ILLNESS AND ON STABILIZED PHARMACOLOGICAL THERAPY, ONE-MONTH TRAINING FOLLOWED BY THREE MONTHS OF HOME PRACTICES OF YOGA AS AN ADD-ON TREATMENT OFFERED SIGNIFICANT ADVANTAGE OVER EXERCISE OR TREATMENT AS USUAL. YOGA HOLDS PROMISE AS A COMPLEMENTARY INTERVENTION IN THE MANAGEMENT OF SCHIZOPHRENIA. 2012 6 1822 51 PROTOCOL TO EVALUATE THE IMPACT OF YOGA SUPPLEMENTATION ON COGNITIVE FUNCTION IN SCHIZOPHRENIA: A RANDOMISED CONTROLLED TRIAL. BACKGROUND: SCHIZOPHRENIA (SZ) IS A CHRONIC ILLNESS THAT IS TREATED SYMPTOMATICALLY. COGNITIVE DYSFUNCTION IS A CORE FEATURE OF SZ THAT IS RELATIVELY INTRACTABLE TO PHARMACOTHERAPY. YOGA CAN IMPROVE COGNITIVE FUNCTION AMONG HEALTHY INDIVIDUALS. A RECENT OPEN TRIAL INDICATED SIGNIFICANT BENEFITS OF YOGA TRAINING (YT) IN CONJUNCTION WITH CONVENTIONAL PHARMACOTHERAPY AMONG PATIENTS WITH SZ. AIMS: TO DESCRIBE THE PROTOCOL FOR AN ONGOING RANDOMISED CONTROLLED TRIAL DESIGNED TO TEST WHETHER THE REPORTED BENEFICIAL EFFECTS OF YT ON COGNITIVE FUNCTION AMONG SZ PATIENTS CAN BE REPLICATED. SECONDARILY, THE EFFECTS OF YT ON DAILY FUNCTIONING LIVING SKILLS ARE EVALUATED. METHODS: CONSENTING PATIENTS WITH SZ RECEIVE ROUTINE CLINICAL TREATMENT AND ARE RANDOMISED TO ADJUNCTIVE YT, ADJUNCTIVE PHYSICAL EXERCISE (PE) OR TREATMENT AS USUAL (PROPOSED N = 234 TOTAL, N = 78 IN EACH GROUP). THE TRIAL INVOLVES YT OR PE 5 DAYS A WEEK AND LASTS 3 WEEKS. PARTICIPANTS ARE EVALUATED THRICE OVER 6 MONTHS. COGNITIVE FUNCTIONS MEASURED BY TRAIL MAKING TEST, UNIVERSITY OF PENNSYLVANIA NEUROCOGNITIVE COMPUTERISED BATTERY WERE PRIMARY OUTCOME MEASURES WHILE CLINICAL SEVERITY AND DAILY FUNCTIONING MEASURED BY INDEPENDENT LIVING SKILLS SURVEY WERE SECONDARY OUTCOME MEASURES. RESULTS: A TOTAL OF 309 PARTICIPANTS HAVE BEEN RANDOMISED AS OF 31 AUGUST 2013, WHICH EXCEEDED BEYOND 294 PROPOSED AFTER ATTRITION. ONCE PARTICIPANTS BEGIN YT OR PE THEY GENERALLY COMPLETE THE PROTOCOL. NO INJURIES HAVE BEEN REPORTED. CONCLUSIONS: SHORT TERM YT IS FEASIBLE AND ACCEPTABLE TO INDIAN SZ PATIENTS. IF BENEFICIAL EFFECTS OF YT ARE DETECTED, IT WILL PROVIDE A NOVEL ADJUNCTIVE COGNITIVE REMEDIATION STRATEGY FOR SZ PATIENTS. 2014 7 2782 38 YOGA THERAPY AS AN ADD-ON TREATMENT IN THE MANAGEMENT OF PATIENTS WITH SCHIZOPHRENIA--A RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: TREATMENT OF SCHIZOPHRENIA HAS REMAINED UNSATISFACTORY DESPITE THE AVAILABILITY OF ANTIPSYCHOTICS. THIS STUDY EXAMINED THE EFFICACY OF YOGA THERAPY (YT) AS AN ADD-ON TREATMENT TO THE ONGOING ANTIPSYCHOTIC TREATMENT. METHOD: SIXTY-ONE MODERATELY ILL SCHIZOPHRENIA PATIENTS WERE RANDOMLY ASSIGNED TO YT (N = 31) AND PHYSICAL EXERCISE THERAPY (PT; N = 30) FOR 4 MONTHS. THEY WERE ASSESSED AT BASELINE AND 4 MONTHS AFTER THE START OF INTERVENTION, BY A RATER WHO WAS BLIND TO THEIR GROUP STATUS. RESULTS: FORTY-ONE SUBJECTS (YT = 21; PT = 20) WERE AVAILABLE AT THE END OF 4 MONTHS FOR ASSESSMENT. SUBJECTS IN THE YT GROUP HAD SIGNIFICANTLY LESS PSYCHOPATHOLOGY THAN THOSE IN THE PT GROUP AT THE END OF 4 MONTHS. THEY ALSO HAD SIGNIFICANTLY GREATER SOCIAL AND OCCUPATIONAL FUNCTIONING AND QUALITY OF LIFE. CONCLUSION: BOTH NON-PHARMACOLOGICAL INTERVENTIONS CONTRIBUTE TO REDUCTION IN SYMPTOMS, WITH YT HAVING BETTER EFFICACY. 2007 8 2864 44 YOGA-BASED INTERVENTION FOR CAREGIVERS OF OUTPATIENTS WITH PSYCHOSIS: A RANDOMIZED CONTROLLED PILOT STUDY. PURPOSE OF THE STUDY: THE USE OF YOGA AS AN INTERVENTION FOR CAREGIVERS OF PATIENTS WITH PSYCHOSIS HAS BEEN POORLY STUDIED. THE CURRENT STUDY AIMED TO TEST THE EFFICACY OF A BRIEF YOGA PROGRAM AS AN INTERVENTION IN CAREGIVERS OF OUTPATIENTS WITH FUNCTIONAL PSYCHOTIC DISORDERS USING A RANDOMIZED CONTROLLED RESEARCH DESIGN. MATERIALS AND METHODS: CAREGIVERS WHO AGREED TO PARTICIPATE IN THE STUDY (N=29) WERE RANDOMIZED INTO YOGA (N=15) OR WAIT-LIST GROUP (N=14). THEY WERE ASSESSED AT BASELINE AND AT THE END OF 3 MONTHS. PATIENTS WHO WERE RANDOMIZED INTO THE YOGA GROUP WERE OFFERED SUPERVISED YOGA TRAINING THRICE A WEEK FOR 4 WEEKS, AFTER WHICH THEY WERE INSTRUCTED TO PRACTICE AT HOME FOR THE NEXT 2 MONTHS. DUE TO THE SMALL SAMPLE SIZE AND SOME VARIABLES NOT BEING NORMALLY DISTRIBUTED, NON-PARAMETRIC STATISTICAL ANALYSIS WAS USED. RESULTS: RESULTS SHOWED SIGNIFICANTLY REDUCED BURDEN SCORES AND IMPROVED QUALITY OF LIFE SCORES IN THE YOGA GROUP AS COMPARED TO THE WAIT-LIST GROUP AT THE END OF 3 MONTHS. THERE WERE NO SIGNIFICANT CHANGES IN ANXIETY AND DEPRESSION SCORES IN CAREGIVERS, OR PSYCHOPATHOLOGY SCORES IN PATIENTS. CONCLUSION: IN CAREGIVERS OF OUTPATIENTS WITH FUNCTIONAL PSYCHOSIS, 4 WEEKS OF TRAINING FOLLOWED BY 3 MONTHS OF HOME PRACTICE OF A YOGA MODULE OFFERED SIGNIFICANT ADVANTAGE OVER WAITLIST. YOGA CAN BE OFFERED AS AN INTERVENTION FOR CAREGIVERS OF PATIENTS WITH SEVERE MENTAL DISORDERS. METHODS OF PROVIDING YOGA INTERVENTION CLOSER TO THE COMMUNITY OR USE OF FLEXIBLE MODULES AT HOSPITALS NEEDS FURTHER STUDY. 2013 9 2441 42 YOGA AND SCHIZOPHRENIA-A COMPREHENSIVE ASSESSMENT OF NEUROPLASTICITY: PROTOCOL FOR A SINGLE BLIND RANDOMIZED CONTROLLED STUDY OF YOGA IN SCHIZOPHRENIA. INTRODUCTION: SCHIZOPHRENIA IS ONE OF THE MOST SEVERE MENTAL DISORDERS WITH A PREVALENCE OF ABOUT 1% AND A LEADING CAUSE OF DISABILITY AMONG YOUNG ADULTS. PHARMACOTHERAPY IS THE MAINSTAY IN THE MANAGEMENT OF SCHIZOPHRENIA. HOWEVER, EVEN WITH THE BEST OF MEDICATION, SEVERAL PROBLEMS LIKE REFRACTORINESS, NEGATIVE SYMPTOMS, FREQUENT RELAPSES, AND COGNITIVE IMPAIRMENTS PERSIST. METHODS: THIS IS A RANDOMIZED-CONTROLLED CLINICAL STUDY INCLUDING PATIENTS FROM AN URBAN TERTIARY HOSPITAL AND A SEMI-URBAN COMMUNITY CENTER, WITH A BETWEEN-GROUP, REPEATED-MEASURES, LONGITUDINAL DESIGN. THIS STUDY WILL RECRUIT 160 PATIENTS WITH DSM 5 DIAGNOSIS OF SCHIZOPHRENIA WHO ARE ON STABLE MEDICATION FOR A MINIMUM OF 6 WEEKS; THEY WILL BE RANDOMLY ASSIGNED INTO 2 ARMS VIZ., YOGA THERAPY (YT), AND TREATMENT-AS-USUAL (TAU) WITH 80 PATIENTS IN EACH ARM. PARTICIPANTS WILL UNDERGO CLINICAL, LABORATORY, AND RADIOLOGICAL ASSESSMENTS AT BASELINE AND AT INTERVALS OF 1 MONTH, 3 MONTHS, AND 6 MONTHS FROM THE BASELINE. IT IS HYPOTHESIZED THAT YOGA WILL IMPROVE PSYCHOPATHOLOGY AND EMOTION PROCESSING, INCREASE SERUM BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) AND PLASMA OXYTOCIN LEVELS AND EFFECT CHANGES IN CEREBRAL ACTIVATION IN AREAS OF THE BRAIN ASSOCIATED WITH SCHIZOPHRENIA. DISCUSSION: THIS STUDY AIMS TO MEASURE THE EFFICACY OF A YOGA-BASED INTERVENTION AS AN ADJUNCT IN PATIENTS WITH SCHIZOPHRENIA AS WELL AS THE MECHANISMS OF THESE EFFECTS. TRIAL REGISTRATION: REGISTERED RETROSPECTIVELY WITH CLINICAL TRIAL REGISTRY - INDIA (CTRI) WITH REGISTRATION NUMBER CTRI/2017/08/009219. 2019 10 1041 47 EFFECTS OF YOGA INTERVENTION ON SLEEP AND QUALITY-OF-LIFE IN ELDERLY: A RANDOMIZED CONTROLLED TRIAL. CONTEXT: YOGA AS A LIFE-STYLE PRACTICE HAS DEMONSTRATED BENEFICIAL EFFECTS. THE ROLE OF YOGA IN THE ELDERLY FOR SUCH BENEFITS MERITS INVESTIGATION. AIMS: THE AIM OF THIS STUDY IS TO EXAMINE THE EFFECTS OF YOGA INTERVENTION ON QUALITY-OF-LIFE (QOL) AND SLEEP QUALITY IN THE ELDERLY LIVING IN OLD AGE HOMES. SETTINGS AND DESIGN: SINGLE BLIND CONTROLLED STUDY WITH BLOCK RANDOMIZATION OF ELDERLY HOMES. MATERIALS AND METHODS: A TOTAL OF 120 SUBJECTS FROM NINE ELDERLY HOMES WERE RANDOMIZED IN TO YOGA GROUP (N=62) AND WAITLIST GROUP (N=58). SUBJECTS IN THE YOGA GROUP WERE GIVEN YOGA INTERVENTION DAILY FOR 1 MONTH AND WEEKLY UNTIL 3 MONTHS AND WERE ENCOURAGED TO PRACTICE YOGA WITHOUT SUPERVISION UNTIL FOR 6 MONTHS. SUBJECTS IN WAITLIST GROUP RECEIVED NO INTERVENTION DURING THIS PERIOD. SUBJECTS WERE EVALUATED WITH WORLD HEALTH ORGANIZATION QUALITY OF LIFE (WHOQOL)-BREF FOR MEASURING QOL AND PITTSBURGH SLEEP QUALITY INDEX FOR SLEEP QUALITY IN THE BASELINE AND AFTER 6 MONTHS. STATISTICAL ANALYSIS: INDEPENDENT T-TEST AND REPEATED MEASURES ANALYSIS OF COVARIANCE RESPECTIVELY WAS USED TO MEASURE THE DIFFERENCE IN OUTCOME MEASURES BETWEEN THE TWO GROUPS AT BASELINE AND AFTER THE STUDY PERIOD. RESULTS: SUBJECTS IN THE YOGA GROUP HAD SIGNIFICANTLY HIGHER NUMBER OF YEARS OF FORMAL EDUCATION. SUBJECTS IN THE YOGA GROUP HAD SIGNIFICANT IMPROVEMENT IN ALL THE DOMAINS OF QOL AND TOTAL SLEEP QUALITY AFTER CONTROLLING FOR THE EFFECT OF BASELINE DIFFERENCE IN EDUCATION BETWEEN THE TWO GROUPS. CONCLUSION: YOGA INTERVENTION APPEARS TO IMPROVE THE QOL AND SLEEP QUALITY OF ELDERLY LIVING IN OLD AGE HOMES. THERE IS A NEED FOR FURTHER STUDIES OVERCOMING THE LIMITATIONS IN THIS STUDY TO CONFIRM THE BENEFITS OF YOGA FOR ELDERLY IN QOL AND SLEEP QUALITY. 2013 11 1267 36 FOLLOW-UP OF YOGA OF AWARENESS FOR FIBROMYALGIA: RESULTS AT 3 MONTHS AND REPLICATION IN THE WAIT-LIST GROUP. OBJECTIVES: PUBLISHED PRELIMINARY FINDINGS FROM A RANDOMIZED-CONTROLLED TRIAL SUGGEST THAT AN 8-WEEK YOGA OF AWARENESS INTERVENTION MAY BE EFFECTIVE FOR IMPROVING SYMPTOMS, FUNCTIONAL DEFICITS, AND COPING ABILITIES IN FIBROMYALGIA. THE PRIMARY AIMS OF THIS STUDY WERE TO EVALUATE THE SAME INTERVENTION'S POSTTREATMENT EFFECTS IN A WAIT-LIST GROUP AND TO TEST THE INTERVENTION'S EFFECTS AT 3-MONTH FOLLOW-UP IN THE IMMEDIATE TREATMENT GROUP. METHODS: UNPAIRED T TESTS WERE USED TO COMPARE DATA FROM A PER PROTOCOL SAMPLE OF 21 WOMEN IN THE IMMEDIATE TREATMENT GROUP WHO HAD COMPLETED TREATMENT AND 18 WOMEN IN THE WAIT-LIST GROUP WHO HAD COMPLETED TREATMENT. WITHIN-GROUP PAIRED T TESTS WERE PERFORMED TO COMPARE POSTTREATMENT DATA WITH 3-MONTH FOLLOW-UP DATA IN THE IMMEDIATE TREATMENT GROUP. THE PRIMARY OUTCOME MEASURE WAS THE FIBROMYALGIA IMPACT QUESTIONNAIRE REVISED (FIQR). MULTILEVEL RANDOM-EFFECTS MODELS WERE ALSO USED TO EXAMINE ASSOCIATIONS BETWEEN YOGA PRACTICE RATES AND OUTCOMES. RESULTS: POSTTREATMENT RESULTS IN THE WAIT-LIST GROUP LARGELY MIRRORED RESULTS SEEN AT POSTTREATMENT IN THE IMMEDIATE TREATMENT GROUP, WITH THE FIQR TOTAL SCORE IMPROVING BY 31.9% ACROSS THE 2 GROUPS. FOLLOW-UP RESULTS SHOWED THAT PATIENTS SUSTAINED MOST OF THEIR POSTTREATMENT GAINS, WITH THE FIQR TOTAL SCORE REMAINING 21.9% IMPROVED AT 3 MONTHS. YOGA PRACTICE RATES WERE GOOD, AND MORE PRACTICE WAS ASSOCIATED WITH MORE BENEFIT FOR A VARIETY OF OUTCOMES. DISCUSSION: THESE FINDINGS INDICATE THAT THE BENEFITS OF YOGA OF AWARENESS IN FIBROMYALGIA ARE REPLICABLE AND CAN BE MAINTAINED. 2012 12 159 38 A RANDOMISED COMPARATIVE TRIAL OF YOGA AND RELAXATION TO REDUCE STRESS AND ANXIETY. OBJECTIVE: TO COMPARE YOGA AND RELAXATION AS TREATMENT MODALITIES AT 10 AND 16 WEEKS FROM STUDY BASELINE TO DETERMINE IF EITHER OF MODALITY REDUCES SUBJECT STRESS, ANXIETY, BLOOD PRESSURE AND IMPROVE QUALITY OF LIFE. DESIGN: A RANDOMISED COMPARATIVE TRIAL WAS UNDERTAKEN COMPARING YOGA WITH RELAXATION. PARTICIPANTS: ONE HUNDRED AND THIRTY-ONE SUBJECTS WITH MILD TO MODERATE LEVELS OF STRESS WERE RECRUITED FROM THE COMMUNITY IN SOUTH AUSTRALIA. INTERVENTIONS: TEN WEEKLY 1- H SESSIONS OF RELAXATION OR HATHA YOGA. MAIN OUTCOME MEASURES: CHANGES IN THE STATE TRAIT PERSONALITY INVENTORY SUB-SCALE ANXIETY, GENERAL HEALTH QUESTIONNAIRE AND THE SHORT FORM-36. RESULTS: FOLLOWING THE 10 WEEK INTERVENTION STRESS, ANXIETY AND QUALITY OF LIFE SCORES IMPROVED OVER TIME. YOGA WAS FOUND TO BE AS EFFECTIVE AS RELAXATION IN REDUCING STRESS, ANXIETY AND IMPROVING HEALTH STATUS ON SEVEN DOMAINS OF THE SF-36. YOGA WAS MORE EFFECTIVE THAN RELAXATION IN IMPROVING MENTAL HEALTH. AT THE END OF THE 6 WEEK FOLLOW-UP PERIOD THERE WERE NO DIFFERENCES BETWEEN GROUPS IN LEVELS OF STRESS, ANXIETY AND ON FIVE DOMAINS OF THE SF-36. VITALITY, SOCIAL FUNCTION AND MENTAL HEALTH SCORES ON THE SF-36 WERE HIGHER IN THE RELAXATION GROUP DURING THE FOLLOW-UP PERIOD. CONCLUSION: YOGA APPEARS TO PROVIDE A COMPARABLE IMPROVEMENT IN STRESS, ANXIETY AND HEALTH STATUS COMPARED TO RELAXATION. 2007 13 428 36 CAN YOGA HAVE ANY EFFECT ON SHOULDER AND ARM PAIN AND QUALITY OF LIFE IN PATIENTS WITH BREAST CANCER? A RANDOMIZED, CONTROLLED, SINGLE-BLIND TRIAL. OBJECTIVE: TO EXAMINE THE EFFECTS OF YOGA ON SHOULDER AND ARM PAIN, QUALITY OF LIFE (QOL), DEPRESSION, AND PHYSICAL PERFORMANCE IN PATIENTS WITH BREAST CANCER. METHODS: THIS PROSPECTIVE, RANDOMIZED STUDY INCLUDED 42 PATIENTS. THE PATIENTS IN GROUP 1 UNDERWENT A 10-WEEK HATHA YOGA EXERCISE PROGRAM. THE PATIENTS IN GROUP 2 WERE INCLUDED IN A 10-WEEK FOLLOW-UP PROGRAM. OUR PRIMARY ENDPOINT WAS ARM AND SHOULDER PAIN INTENSITY. RESULTS: THE GROUP RECEIVING YOGA SHOWED A SIGNIFICANT IMPROVEMENT IN THEIR PAIN SEVERITY FROM BASELINE TO POST-TREATMENT, AND THESE BENEFITS WERE MAINTAINED AT 2.5 MONTHS POST-TREATMENT. WHEN COMPARED TO THE CONTROL GROUP, THERE WERE NO STATISTICALLY SIGNIFICANT DIFFERENCES BETWEEN THE 2 GROUPS WITH RESPECT TO THE PARAMETERS ASSESSED AT THE END OF WEEK 10. CONCLUSION: YOGA WAS AN EFFECTIVE AND SAFE EXERCISE FOR ALLEVIATING SHOULDER AND ARM PAIN, WHICH IS A COMPLICATION WITH A HIGH PREVALENCE IN PATIENTS WITH BREAST CANCER. 2018 14 2222 45 THE IMPACT OF MODIFIED HATHA YOGA ON CHRONIC LOW BACK PAIN: A PILOT STUDY. PURPOSE: THE PURPOSE OF THIS RANDOMIZED PILOT STUDY WAS TO EVALUATE A POSSIBLE DESIGN FOR A 6-WEEK MODIFIED HATHA YOGA PROTOCOL TO STUDY THE EFFECTS ON PARTICIPANTS WITH CHRONIC LOW BACK PAIN. PARTICIPANTS: TWENTY-TWO PARTICIPANTS (M = 4; F = 17), BETWEEN THE AGES OF 30 AND 65, WITH CHRONIC LOW BACK PAIN (CLBP) WERE RANDOMIZED TO EITHER AN IMMEDIATE YOGA BASED INTERVENTION, OR TO A CONTROL GROUP WITH NO TREATMENT DURING THE OBSERVATION PERIOD BUT RECEIVED LATER YOGA TRAINING. METHODS: A SPECIFIC CLBP YOGA PROTOCOL DESIGNED AND MODIFIED FOR THIS POPULATION BY A CERTIFIED YOGA INSTRUCTOR WAS ADMINISTERED FOR ONE HOUR, TWICE A WEEK FOR 6 WEEKS. PRIMARY FUNCTIONAL OUTCOME MEASURES INCLUDED THE FORWARD REACH (FR) AND SIT AND REACH (SR) TESTS. ALL PARTICIPANTS COMPLETED OSWESTRY DISABILITY INDEX (ODI) AND BECK DEPRESSION INVENTORY (BDI) QUESTIONNAIRES. GUIDING QUESTIONS WERE USED FOR QUALITATIVE DATA ANALYSIS TO ASCERTAIN HOW YOGA PARTICIPANTS PERCEIVED THE INSTRUCTOR, GROUP DYNAMICS, AND THE IMPACT OF YOGA ON THEIR LIFE. ANALYSIS: TO ACCOUNT FOR DROP OUTS, THE DATA WERE DIVIDED INTO BETTER OR NOT CATEGORIES, AND ANALYZED USING CHI-SQUARE TO EXAMINE DIFFERENCES BETWEEN THE GROUPS. QUALITATIVE DATA WERE ANALYZED THROUGH FREQUENCY OF POSITIVE RESPONSES. RESULTS: POTENTIALLY IMPORTANT TRENDS IN THE FUNCTIONAL MEASUREMENT SCORES SHOWED IMPROVED BALANCE AND FLEXIBILITY AND DECREASED DISABILITY AND DEPRESSION FOR THE YOGA GROUP BUT THIS PILOT WAS NOT POWERED TO REACH STATISTICAL SIGNIFICANCE. SIGNIFICANT LIMITATIONS INCLUDED A HIGH DROPOUT RATE IN THE CONTROL GROUP AND LARGE BASELINE DIFFERENCES IN THE SECONDARY MEASURES. IN ADDITION, ANALYSIS OF THE QUALITATIVE DATA REVEALED THE FOLLOWING FREQUENCY OF RESPONSES (1) GROUP INTERVENTION MOTIVATED THE PARTICIPANTS AND (2) YOGA FOSTERED RELAXATION AND NEW AWARENESS/LEARNING. CONCLUSION: A MODIFIED YOGA-BASED INTERVENTION MAY BENEFIT INDIVIDUALS WITH CLB, BUT A LARGER STUDY IS NECESSARY TO PROVIDE DEFINITIVE EVIDENCE. ALSO, THE IMPACT ON DEPRESSION AND DISABILITY COULD BE CONSIDERED AS IMPORTANT OUTCOMES FOR FURTHER STUDY. ADDITIONAL FUNCTIONAL OUTCOME MEASURES SHOULD BE EXPLORED. THIS PILOT STUDY SUPPORTS THE NEED FOR MORE RESEARCH INVESTIGATING THE EFFECT OF YOGA FOR THIS POPULATION. 2004 15 1542 33 KRIYA YOGA IN PATIENTS WITH DEPRESSIVE DISORDERS: A PILOT STUDY. BACKGROUND AND OBJECTIVES DESPITE THE EASY ACCEPTABILITY AND HOLISTIC NATURE OF KRIYA YOGA, THERE ARE NO STUDIES EVALUATING THE ROLE OF KRIYA YOGA INTERVENTION ON DEPRESSION. THE OBJECTIVE OF THE CURRENT STUDY WAS TO ASSESS THE FEASIBILITY AND EFFECT OF ADJUNCTIVE KRIYA YOGA ON DEPRESSION. METHODS PATIENTS WITH MAJOR DEPRESSIVE DISORDER WHO OPTED FOR KRIYA YOGA WERE RECRUITED INTO THE INTERVENTION GROUP (ADJUNCTIVE KRIYA YOGA) AND THOSE ON PSYCHOTROPIC MEDICATION ALONE WERE ENROLLED INTO THE CONTROL GROUP. THE HAMILTON DEPRESSION RATING SCALE (HDRS) MEASUREMENTS WERE RECORDED AT BASELINE, END OF 2, 4, AND 8 WEEKS. RESULTS HDRS SCORES OF THE INTERVENTION GROUP ( N = 29) WERE FOUND TO BE SIGNIFICANTLY LESSER THAN THAT OF THE CONTROL GROUP ( N = 52) BY THE END OF 2, 4, AND 8 WEEKS. THE REMISSION RATE WAS ALSO SIGNIFICANTLY GREATER IN THE INTERVENTION GROUP. CONCLUSION KRIYA YOGA INTERVENTION WAS FOUND TO BE FEASIBLE, AS WELL AS IMPROVED THE SEVERITY OF DEPRESSION. 2021 16 2235 32 THE IMPACT OF YOGA UPON FEMALE PATIENTS SUFFERING FROM HYPOTHYROIDISM. OBJECTIVE: TO STUDY THE EFFECT OF YOGA ON THE QUALITY OF LIFE OF FEMALE HYPOTHYROID PATIENTS. DESIGN: THE WHO QUALITY OF LIFE SCALE(22) WAS USED TO ASSESS THE QUALITY OF LIFE OF 20 FEMALE HYPOTHYROID PATIENTS. SUBJECTS ATTENDED ONE HOUR YOGA SESSIONS DAILY FOR A PERIOD OF ONE MONTH. A PRETEST-POST-TEST RESEARCH DESIGN WAS USED FOR DATA ANALYSIS. RESULTS: PATIENTS' QUALITY OF LIFE SCORES FOLLOWING THE YOGA PROGRAM WERE GREATER THAN SCORES OBTAINED PRIOR TO UNDERTAKING YOGA (P < 0.01). PATIENTS ALSO REPORTED SIGNIFICANT IMPROVEMENT IN THEIR PERCEPTION OF THE OVERALL QUALITY OF LIFE AND OF THEIR HEALTH POST YOGA INTERVENTION. CONCLUSIONS: IT CAN BE CONCLUDED THAT YOGA IS VALUABLE IN HELPING THE HYPOTHYROID PATIENTS TO MANAGE THEIR DISEASE-RELATED SYMPTOMS. YOGA MAY BE CONSIDERED AS SUPPORTIVE OR COMPLEMENTARY THERAPY IN CONJUNCTION WITH MEDICAL THERAPY FOR THE TREATMENT OF HYPOTHYROID DISORDER. 2011 17 1076 37 EFFECTS OF YOGA ON PHYSIOLOGICAL INDICES, ANXIETY AND SOCIAL FUNCTIONING IN MULTIPLE SCLEROSIS PATIENTS: A RANDOMIZED TRIAL. INTRODUCTION: MULTIPLE SCLEROSIS (MS) AS A CHRONIC DISEASE COULD AFFECT PATIENTS' VARIOUS DOMAINS OF LIFE. AIM: THIS STUDY WAS CONDUCTED TO STUDY THE EFFECT OF YOGA ON THE PHYSIOLOGICAL INDICES, ANXIETY AND SOCIAL FUNCTIONING OF PATIENTS WITH MS IN SOUTHWEST, IRAN. MATERIALS AND METHODS: IN THIS CLINICAL TRIAL STUDY, 60 MS PATIENTS WERE ENROLLED ACCORDING TO INCLUSION CRITERIA AND RANDOMLY ASSIGNED TO TWO GROUPS OF 30 EACH. PRIOR TO AND AFTER INTERVENTION, THE PATIENTS' VITAL SIGNS WERE MEASURED. FOR CASE GROUP YOGA EXERCISES WERE PERFORMED THREE SESSIONS A WEEK FOR 12 WEEKS WHILE CONTROL GROUP PERFORMED NO EXERCISE. THE DATA WERE GATHERED BY QUESTIONNAIRE AND ANALYSED BY DESCRIPTIVE AND ANALYTICAL STATISTICS IN SPSS. RESULTS: PRIOR TO INTERVENTION, THERE WAS NO SIGNIFICANT DIFFERENCE IN FATIGUE SEVERITY AND PAIN BETWEEN THE TWO GROUPS BUT THE MEAN FATIGUE SEVERITY AND PAIN IN CASE GROUP DECREASED COMPARED TO THE CONTROL GROUP AFTER THE INTERVENTION. PRIOR TO INTERVENTION, THERE WAS NO SIGNIFICANT DIFFERENCE IN MEAN PHYSIOLOGICAL INDICES BETWEEN THE TWO GROUPS BUT THE MEAN PHYSIOLOGICAL INDICES IN CASE GROUP DECREASED SIGNIFICANTLY AFTER THE INTERVENTION (P<0.05). CONCLUSION: YOGA IS LIKELY TO INCREASE SELF-EFFICACY OF MS PATIENTS THROUGH ENHANCING PHYSICAL ACTIVITY, INCREASING THE STRENGTH OF LOWER LIMBS AND BALANCE, AND DECREASING FATIGUE AND PAIN, AND FINALLY TO PROMOTE SOCIAL FUNCTIONING AND TO RELIEVE STRESS AND ANXIETY IN THESE PATIENTS. 2016 18 2119 30 THE EFFECT OF YOGA THERAPY ON SELECTED PSYCHOLOGICAL VARIABLES AMONG MALE PATIENTS WITH INSOMNIA. BACKGROUND: AN ESTIMATED 30-50% OF THE GENERAL POPULATION IS AFFECTED BY INSOMNIA AND 10% HAVE CHRONIC INSOMNIA. YOGA THERAPY IS BENEFICIAL IN SUCH DISORDERS AND IT HAS FEWER SIDE EFFECTS. AIM: THE AIM OF THIS STUDY WAS TO FIND OUT THE EFFECT OF YOGA THERAPY ON SELECTED PSYCHOLOGICAL VARIABLES AMONG MEN WITH INSOMNIA. METHODS: FORTY MALES WITH INSOMNIA WERE DIVIDED RANDOMLY INTO 2 GROUPS (THE EXPERIMENTAL AND THE CONTROL GROUPS). THE EXPERIMENTAL GROUP RECEIVED EIGHT WEEKS OF YOGA THERAPY, WHILE THE CONTROL GROUP DID NOT RECEIVE ANY THERAPY. THE PRE AND POST TREATMENT STRESS AND THE SELF CONFIDENCE SCORES WERE TAKEN. RESULTS: THERE WAS A SIGNIFICANT IMPROVEMENT IN THE STRESS SCORES AND THE SELF CONFIDENCE SCORES IN THE EXPERIMENTAL GROUP. THERE WERE NEITHER ANY SIDE EFFECTS NOR ANY DROP OUTS. CONCLUSION: WE CONCLUDE THAT YOGA IS AN EFFECTIVE TREATMENT OPTION FOR THE PATIENTS WITH INSOMNIA. THERE ARE NO MAJOR SIDE EFFECTS. 2013 19 2508 49 YOGA BREATHING FOR CANCER CHEMOTHERAPY-ASSOCIATED SYMPTOMS AND QUALITY OF LIFE: RESULTS OF A PILOT RANDOMIZED CONTROLLED TRIAL. BACKGROUND: MANY DEBILITATING SYMPTOMS ARISE FROM CANCER AND ITS TREATMENT THAT ARE OFTEN UNRELIEVED BY ESTABLISHED METHODS. PRANAYAMA, A SERIES OF YOGIC BREATHING TECHNIQUES, MAY IMPROVE CANCER-RELATED SYMPTOMS AND QUALITY OF LIFE, BUT IT HAS NOT BEEN STUDIED FOR THIS PURPOSE. OBJECTIVES: A PILOT STUDY WAS PERFORMED TO EVALUATE FEASIBILITY AND TO TEST THE EFFECTS OF PRANAYAMA ON CANCER-ASSOCIATED SYMPTOMS AND QUALITY OF LIFE. DESIGN: THIS WAS A RANDOMIZED CONTROLLED CLINICAL TRIAL COMPARING PRANAYAMA TO USUAL CARE. SETTING: THE STUDY WAS CONDUCTED AT A UNIVERSITY MEDICAL CENTER. SUBJECTS: PATIENTS RECEIVING CANCER CHEMOTHERAPY WERE RANDOMIZED TO RECEIVE PRANAYAMA IMMEDIATELY OR AFTER A WAITING PERIOD (CONTROL GROUP). INTERVENTIONS: THE PRANAYAMA INTERVENTION CONSISTED OF FOUR BREATHING TECHNIQUES TAUGHT IN WEEKLY CLASSES AND PRACTICED AT HOME. THE TREATMENT GROUP RECEIVED PRANAYAMA DURING TWO CONSECUTIVE CYCLES OF CHEMOTHERAPY. THE CONTROL GROUP RECEIVED USUAL CARE DURING THEIR FIRST CYCLE, AND RECEIVED PRANAYAMA DURING THEIR SECOND CYCLE OF CHEMOTHERAPY. OUTCOME MEASURES: FEASIBILITY, CANCER-ASSOCIATED SYMPTOMS (FATIGUE, SLEEP DISTURBANCE, ANXIETY, DEPRESSION, STRESS), AND QUALITY OF LIFE WERE THE OUTCOMES. RESULTS: CLASS ATTENDANCE WAS NEARLY 100% IN BOTH GROUPS. SIXTEEN (16) PARTICIPANTS WERE INCLUDED IN THE FINAL INTENT-TO-TREAT ANALYSES. THE REPEATED-MEASURES ANALYSES DEMONSTRATED THAT ANY INCREASE IN PRANAYAMA DOSE, WITH DOSE MEASURED IN THE NUMBER OF HOURS PRACTICED IN CLASS OR AT HOME, RESULTED IN IMPROVED SYMPTOM AND QUALITY-OF-LIFE SCORES. SEVERAL OF THESE ASSOCIATIONS--SLEEP DISTURBANCE (P=0.04), ANXIETY (P=0.04), AND MENTAL QUALITY OF LIFE (P=0.05)--REACHED OR APPROACHED STATISTICAL SIGNIFICANCE. CONCLUSIONS: YOGA BREATHING WAS A FEASIBLE INTERVENTION AMONG PATIENTS WITH CANCER RECEIVING CHEMOTHERAPY. PRANAYAMA MAY IMPROVE SLEEP DISTURBANCE, ANXIETY, AND MENTAL QUALITY OF LIFE. A DOSE-RESPONSE RELATIONSHIP WAS FOUND BETWEEN PRANAYAMA USE AND IMPROVEMENTS IN CHEMOTHERAPY-ASSOCIATED SYMPTOMS AND QUALITY OF LIFE. THESE FINDINGS NEED TO BE CONFIRMED IN A LARGER STUDY. 2012 20 1129 38 EFFICACY OF YOGA AS AN ADD-ON TREATMENT FOR IN-PATIENTS WITH FUNCTIONAL PSYCHOTIC DISORDER. CONTEXT: THE EFFICACY OF YOGA AS AN INTERVENTION FOR IN-PATIENTS WITH PSYCHOSIS IS AS YET UNKNOWN; ALTHOUGH, PREVIOUS STUDIES HAVE SHOWN EFFICACY IN STABILIZED OUT-PATIENTS WITH SCHIZOPHRENIA. AIM: THIS STUDY AIMED TO COMPARE THE EFFECT OF ADD-ON YOGA THERAPY OR PHYSICAL EXERCISE ALONG WITH STANDARD PHARMACOTHERAPY IN THE TREATMENT OF IN-PATIENTS WITH PSYCHOSIS. SETTINGS AND DESIGN: THIS STUDY WAS PERFORMED IN AN IN-PATIENT SETTING USING A RANDOMIZED CONTROLLED SINGLE BLIND DESIGN. MATERIALS AND METHODS: A TOTAL OF 88 CONSENTING IN-PATIENTS WITH PSYCHOSIS WERE RANDOMIZED INTO YOGA THERAPY GROUP (N=44) AND PHYSICAL EXERCISE GROUP (N=44). SIXTY PATIENTS COMPLETED THE STUDY PERIOD OF 1(1/2) MONTHS. PATIENTS WHO COMPLETED IN THE YOGA GROUP (N=35) AND IN THE EXERCISE GROUP (N=25) WERE SIMILAR ON THE DEMOGRAPHIC PROFILE, ILLNESS PARAMETERS AND PSYCHOPATHOLOGY SCORES AT BASELINE. RESULTS: THE TWO TREATMENT GROUPS WERE NOT DIFFERENT ON THE CLINICAL SYNDROME SCORES AT THE END OF 2 WEEKS. AT THE END OF 6 WEEKS, PATIENTS IN THE YOGA GROUP HOWEVER HAD LOWER MEAN SCORES ON CLINICAL GLOBAL IMPRESSION SEVERITY (CGIS), POSITIVE AND NEGATIVE SYNDROME SCALE (TOTAL AND GENERAL PSYCHOPATHOLOGY SUBSCALE) AND HAMILTON DEPRESSION RATING SCALE (HDRS) (P<0.05). REPEATED MEASURE ANALYSIS OF VARIANCE DETECTED AN ADVANTAGE FOR YOGA OVER EXERCISE IN REDUCING THE CLINICAL CGIS AND HDRS SCORES. CONCLUSION: ADDING YOGA INTERVENTION TO STANDARD PHARMACOLOGICAL TREATMENT IS FEASIBLE AND MAY BE BENEFICIAL EVEN IN THE EARLY AND ACUTE STAGE OF PSYCHOSIS. 2013